Safety and Pharmacokinetic Study of NPT 2042 Soft-gelatin Capsules Administered Orally to Healthy Adult Subjects

Conditions:   Epilepsy;   Alzheimer Disease;   Epilepsy Intractable Intervention:   Drug: NPT 2042 (bumetanide analog) or Matching Placebo Sponsor:   NeuroPro Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials